echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Chemotherapy can destroy the gut health of cancer patients

    Chemotherapy can destroy the gut health of cancer patients

    • Last Update: 2021-08-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     


    Picture: Dr.


    Source: South African Institute of Health and Medical Research (SAHMRI)

    New research on BMC cancer shows that myelosuppressive chemotherapy destabilizes the gut microbiota of patients with solid organ cancers


    The SAHMRI and Flinders University study evaluated the intestinal health of men and women who received conventional chemotherapy for cancers such as breast and lung cancer without exposure to antibiotics


    The study’s first author, infectious disease expert and clinical microbiologist Dr.


    Analysis of the subjects’ gut microbiota before and during chemotherapy revealed significant changes


    Although the test proved that the microbiota was significantly altered, Dr.


    "What we are seeing may be a good thing, because changes in the microbiota may trigger the body's immune response against cancer," said Dr.


    She added that these findings make a significant contribution to our ability to predict the response of an individual's microbiome to chemotherapy before chemotherapy occurs


    The SAHMRI Microbiome and Host Health Laboratory, in collaboration with the Flinders Cancer Innovation Center, will soon begin a larger study to examine whether changes in the gut microbiome during chemotherapy are related to the patient’s risk of infection or treatment response


    It is hoped that this research will enable clinicians to better tailor treatments for patients to improve treatment results


    ###

    The paper, Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome (2021) by Lito E Papanicolas, Sarah K Sims, Steven L Taylor, Sophie J Miller, Christos S Karapetis, Steve L Wesselingh, David L Gordon and Geraint B Rogers has been published in BMC Cancer 21, 591 (2021).


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.